| Literature DB >> 33855600 |
Andrea Balla1, Francesca Meoli2, Livia Palmieri2, Diletta Corallino2, Maria Carlotta Sacchi3, Emanuela Ribichini3, Diego Coletta4, Annamaria Pronio5, Danilo Badiali3, Alessandro M Paganini2.
Abstract
PURPOSE: Aim of this systematic review is to assess the changes in esophageal motility and acid exposure of the esophagus through esophageal manometry and 24-hours pH-monitoring before and after laparoscopic sleeve gastrectomy (LSG).Entities:
Keywords: 24h-pH-impedance; Gastroesophageal reflux disease (GERD); Manometry; Sleeve gastrectomy; pH-metry
Mesh:
Year: 2021 PMID: 33855600 PMCID: PMC8803809 DOI: 10.1007/s00423-021-02171-3
Source DB: PubMed Journal: Langenbecks Arch Surg ISSN: 1435-2443 Impact factor: 3.445
Keywords used for research in the PubMed, Embase, Cochrane, and Web of Science databases
| sleeve gastrectomy AND ph manometry | |
| sleeve gastrectomy AND ph-manometry | |
| bariatric surgery AND ph manometry | |
| bariatric surgery AND ph-manometry | |
| sleeve gastrectomy AND manometry | |
| bariatric surgery AND manometry | |
| sleeve gastrectomy AND reflux | |
| bariatric surgery AND reflux | |
| sleeve gastrectomy AND GERD | |
| bariatric surgery AND GERD | |
| sleeve gastrectomy AND 24h-pH-impedance | |
| sleeve gastrectomy AND 24h pH impedance | |
| sleeve gastrectomy AND pH-impedance | |
| sleeve gastrectomy AND pH impedance | |
| bariatric surgery AND 24h-pH-impedance | |
| bariatric surgery AND 24h pH impedance | |
| bariatric surgery AND pH-impedance | |
| bariatric surgery AND pH impedance |
Fig. 1Preferred reporting items for systematic review and meta-analysis (PRISMA) flow diagram [14]. SG: sleeve gastrectomy
Assessment of the articles quality based on the Newcastle-Ottawa scale (NOS) [16]
| Author, year, type of study | Selection | Comparability | Outcomes | Total Score | Assessment |
|---|---|---|---|---|---|
| 1 2 3 4 | 5 | 6 7 8 | |||
| Braghetto, 2010, prospective [ | - - * * | - - | * - * | 4 | Poor |
| Gorodner, 2015, prospective [ | * - * * | - - | * * - | 5 | Poor |
| Valezi, 2017, prospective [ | * * * * | * - | * * * | 8 | Good |
| De Angulo, 2019, prospective [ | * - * * | - - | * * * | 6 | Poor |
| Sioka, 2017, prospective [ | * - * * | - - | * * * | 6 | Poor |
| Rebecchi, 2014, prospective [ | * - * * | - - | * * * | 6 | Poor |
| Kleidi, 2013, prospective [ | * - * * | - - | * - * | 5 | Poor |
| Gemici, 2020, retrospective [ | * - * * | - - | * - * | 5 | Poor |
| Coupaye, 2018, prospective [ | - - * * | - - | * * * | 5 | Poor |
| Del Genio 2014, prospective [ | * - * * | - - | * * * | 6 | Poor |
| Tolone, 2020, prospective [ | * - * * | - * | * * * | 7 | Fair |
| Burgerhart, 2014, prospective [ | * - * * | - - | * - * | 5 | Poor |
| Georgia, 2017, prospective [ | * - * * | - - | * * * | 6 | Poor |
| Świdnicka-Siergiejko, 2018, prospective [ | * - * * | - - | * * * | 6 | Poor |
| Thereaux, 2016, prospective [ | * * * * | * * | * - * | 8 | Good |
| Yormaz, 2017, retrospective [ | * * * * | * * | * * * | 9 | Good |
Assessment of risk of bias of the included articles based on Risk Of Bias In Non-randomized Studies of Interventions (ROBIN-I) [17]
| Author, year, type of study | Bias due to confounding | Bias in selection participants | Bias in classification of interventions | Bias due to deviations from intended interventions | Bias due to missing data | Bias in measurement of outcomes | Bias in selection of reported result | Overall |
|---|---|---|---|---|---|---|---|---|
| Braghetto, 2010, prospective [ | Serious | Low | Low | Low | Low | Moderate | Moderate | Serious |
| Gorodner, 2015, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Valezi, 2017, prospective [ | Moderate | Low | Low | Low | Low | Low | Low | Moderate |
| De Angulo, 2019, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Sioka, 2017, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Rebecchi, 2014, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Kleidi, 2013, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Gemici, 2020, retrospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Coupaye, 2018, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Del Genio 2014, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Tolone, 2020, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Burgerhart, 2014, prospective [ | Serious | Low | Low | Low | Moderate | Low | Low | Serious |
| Georgia, 2017, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Świdnicka-Siergiejko, 2018, prospective [ | Serious | Low | Low | Low | Low | Low | Low | Serious |
| Thereaux, 2016, prospective [ | Low | Low | Low | Low | Moderate | Moderate | Low | Moderate |
| Yormaz, 2017, retrospective [ | Low | Low | Moderate | Low | Moderate | Moderate | Moderate | Moderate |
Low: low risk of bias (the study is comparable to a randomized trial). Moderate: moderate risk of bias (the study provides sound evidence for a non-randomized study but cannot be considered comparable to a randomized trial). Serious: serious risk of bias (the study has important problems)
Pre- and intraoperative results
| Author | Preoperative exclusion criteria | Number of patients | Number of | Mean age ± SD (range) | Hiatal hernia/hiatoplasty | Bougie size (French) | Distance of gastrectomy from pylorus (cm) |
|---|---|---|---|---|---|---|---|
| Braghetto et al. [ | GERD symptoms, esophagitis, abnormal manometry | 20 | 17 (85)/3 (15) | 37.6 ± 12.6 (23–55) | - | 32 oversew | 2-3 |
| Gorodner et al. [ | Erosive esophagitis, Pathological pH-monitoring | 14 | 13 (92.9)/1 (72.1) | 42 ± 12 | 4/0 (barium swallow) | 36 oversew | 6 |
| Valezi et al. [ | Previous gastric surgery, history of GERD, esophagitis, hiatal hernia, conditions that could affect esophageal motility | 73 | 55 (75.3)/18 (24.7) | 40.2 | - | 32 oversew | 4 |
| De Angulo et al. [ | - | 26 | 14 (53.8)/12 (46.2) | 45.27 ± 10.14 | 5/1 (endoscopy) | 36 | 5 |
| Sioka et al. [ | - | 18 | 10 (55.6)/8 (44.4) | 40.7 ± 8.1 (30–56) | - | 36 | 5 |
| Rebecchi et al. [ | Large hiatal hernia, previous gastric surgery | 65 † | n.r. | n.r. | 11/0 (barium swallow) | 36 | 6 |
| Kleidi et al. [ | Previous upper gastrointestinal surgery, history of GERD, upper dysmotility, medication for upper gastrointestinal disease | 23 | 11 (47.8)/12 (52.2) | 38.5 ± 10.9 | - | 34 | 3-4 |
| Gemici et al. [ | Esophageal motor disorder, advanced stage of hiatal hernia | 62 | 50 (80.6)/12 (19.4) | 40.3 ± 10.6 (20–58) | - | 36 | 2-3 |
| Coupaye et al. [ | Erosive esophagitis. PPI dependency for GERD | 30* 47^ | 46 (97.9)/1 (2.1) ‡ | 41.1 ± 9.4 | 4/0 (n.r.) | 36 | 5-6 |
| Del Genio et al. [ | GERD symptoms, previous upper gastrointestinal surgery, hiatal hernia, erosive esophagitis, Barrett esophagus | 25 | 18 (72)/7 (28) | Median 42 (22–62) | - | 40 oversew | n.s. |
| Tolone et al. [ | Signs of pathological GERD, hiatal hernia, esophagitis, Barret esophagus | 26 | n.r. | n.r. | - | 38 | 6 |
| Burgerhart et al. [ | - | 20* 15^ | 16 (80)/4 (20) n.r. | 43 ± 12 n.r. | 5/0 (manometry) | 34 | 6 |
| Georgia et al. [ | Erosive esophagitis, use of PPI, GERD symptoms | 12 | 9 (75)/3 (25) | 39.67 (SE 1.86) (23–55) | - | 38 | 2-3 |
Świdnicka-Siergiejko et al. [ | Hiatal hernia > 3 cm, patients with esophageal manometry abnormalities | 53 | 32 (60.4)/21 (39.6) | Median 41.6 (20 - 70) | - | - | - |
| Thereaux et al. [ | Erosive esophagitis,PPI-refractory, GERD | 50 | 39 (78)/11 (22) | n.r. | 3/3 (manometry) | 96 | 6 |
| Yormaz et al | Previous thoracic, esophageal or gastric surgery, hiatal hernia, gastrointestinal pathology, or malignancy | 152 | 104 (68.4)/48 (31.6) | 41.2 (26–65) | - | 36 | 2 and 6 |
PPI proton pump inhibitor, GERD gastroesophageal reflux disease. †: initially 71 patients were included, but 6 patients were lost at follow-up, the number of women/men lost is not reported. *: number of patients evaluated by manometry. ^ number of patients evaluated by pH-monitoring. ‡: number of women/men who underwent manometry and/or pH-metry is not reported. n.r. not reported, SD standard deviation, SE standard error
Manometric and pH-monitoring results
| Author | Timing after | Type of manometry | Postoperative manometric parameters | Manometric results | Type of 24-hours pH monitoring | Postoperative pH-monitoring parameters | pH-monitoring results |
|---|---|---|---|---|---|---|---|
| Braghetto et al. [ | 6 | Conventional | LESP: 10.5 ± 6.06 mmHg (12.3 - 23.9) | LES hypotonia de novo in 85% | - | - | - |
| Gorodner et al. [ | 12 | Conventional | LES length: 3.2 ± 1.3 cm LESP: 12.4 ± 4.5 mmHg NSEMD: 2 IEM: 1 DEA: 75 ± 26 mmHg | Decrease LESP | pH-metry | DMS: 28.4 ± 19 NRE: 25.4 ± 12.8 NRE > 5: 4.7 ± 3.9 LER: 27.3 ± 24.6 TAET: 110 ± 83 | Not change: 7% Improvement: 21% De novo: 36% |
| Valezi et al. [ | 12 | Conventional | LESP: 12.6 ± 8.7 mmHg Wave amplitude: 146.5 ± 37.7 mmHg Wave duration: 5.7 ± 1.1 mmHg Normal peristalsis: 90% | Decrease LES pressure LES hypotonia: from 11% to 44% Increase of amplitude contraction wave Peristalsis: from 100% to 90% | - | - | - |
| De Angulo et al. [ | 12 | Conventional | LES length: 4.06 ± 1.21 cm Wave amplitude: 98.38 ± 34.26 mmHg LESP: 13.2 ± 6.19 mmHg | Decrease contraction and LESP | pH-metry | DMS: 37.3 ± 29.77 NRE > 5: 3.92 ± 4.1 NRE: 135.76 ± 97.79 LER: 21.11 ± 21.04 TAET: 113.46 ± 100.13 | Improvement: 50% De novo: 66% |
| Sioka et al. [ | 6-15 | Conventional | Wave amplitude: 69.8 ± 26.3 mmHg | Decrease of body contraction, and LESP | - | - | - |
| Rebecchi et al. [ | 24 | Conventional | Group A LES length: 3.1 ± 0.4 cm LESP: 10.1 ± 4.2 mmHg Distal esophageal wave amplitude: 82.8 ± 18.9 mmHg Group B LES length: 4 ± 0.4 cm LESP: 16.4 ± 4.5 mmHg Distal esophageal wave amplitude: 90.6 ± 19.8 mmHg | Not significant change in amplitude and LESP | pH-metry | Group A DMS: 10.6 ± 5.8 TAE: 4.2 ± 2.6 % Group B DMS: 12 ± 2.3 TAE: 3.5 ± 1.1 % | Not change: 14.3% Improvement 85.7% De novo: 18.9% |
| Kleidi et al. [ | Conventional | Total LES length: 4.1 ± 1 cm Abdominal LES length: 2.4 ± 0.9 cm LESP: 21.1 mmHg Contraction amplitude: 133.3 ± 58.3 mmHg | Increase LESP | - | - | - | |
| Gemici et al. [ | 3 | Conventional | LES length: 3.34 ± 0.72 cm (2-5) LESP: 16.6 ± 4.4 mmHg (7-29) Amplitude pressure of the esophagus: 80.8 ± 19.3 mmHg (48-133) LESR: 7.27 ± 3.57 mmHg (0-14) Relaxation time of LES: 6.51 ± 1.96 seconds (1.8-10.7) IGP: 10.95 ± 2.87 mmHg (3-19) | Not significant change in amplitude Decrease LESP | pH-metry | DMS: 33.84 ± 26.55 (0.95–113.65) TAE: 9.84 ± 8.09 % (0.20–31.7) NRE: 65.52 ± 50.29 (1–235.9) NRE > 5: 5.36 ± 5.23 (0–25.4) | Significant increase of DMS |
| Coupaye et al. [ | 12 | HRM | LES length: 27.5 ± 25.6 cm LESP: 17.4 ± 9.7 mmHg DCI: 1124 ± 1211 Normal esophageal contractions: 51 ± 31 Patients with IEM: 15 (50%) IGP: 11.7 ± 3.5 mmHg | Decrease of % of normal peristalsis, increase of patients with IEM, Not significant change in LESP | pH-metry | DMS: 23.8 ± 20.5 TAE: 6.3 ± 5.3 % NRE: 65 ± 51 | Healing: 44% Improvement: 19% Worsening: 37% De novo: 53% |
| Del Genio et al. [ | 13 | HRM | Median LES length: 3.8 cm Median LESP: 22 mmHg (7-29) Patients with IEM: 46 % (30-50) Complete bolus transit: 50 % (30-70) | Increase of IEM Not significant change in vLESP | Impedance | Median DMS: 18.2 Median total NRE: 53 Median total acid reflux episodes: 16 Median total non-acid reflux episodes: 36 Median acid postprandial retrograde movements: 8 Median non-acid postprandial retrograde movements: 20 Median bolus clearance time: 34 | Increase of DMS |
| Tolone et al. [ | 12 | HRM | Median LESP: 22 mmHg Median LES length: 23 cm Median IRP: 6.3 mmHg Median IGP: 18.8 mmHg | Increase of IGP | Impedance | Raw data not reported | Increase in AET and total number of refluxes |
| Burgerhart et al. [ | 3 | HRM | LESP: 11 ± 7 mmHg DCI: 1537.4 ± 1671.8 IRP4: 2.1 ± 5.2 mmHg IGP: 6.5 ± 4.1 mmHg | Decrease of DCI, LESP, IRP and IGP | Impedance | TAET: 12.4 ± 10.4 % TAE: 37 ± 31.8 Total non-acid reflux episodes: 0.2 ± 0.7 NRE > 5: 5.7 (0–27) LER: 25.4 (1.9– 81) | TAET significantly increase |
| Georgia et al. [ | 12 | - | - | - | Impedance | DMS: 47 TAET: 13.27 % Acid reflux upright distal activity: 61.42 Non-acid reflux upright distal activity: 46.75 Bolus exposure acid time: 4.23 % Bolus exposure non-acid time: 4.29 % | Improvement: 8%Worsening: 80% De novo: 50% |
Świdnicka-Siergiejko et al. [ | 10-12 | - | - | - | Impedance | Median TAE: 54 Median TAET: 40 Median acid clearance time: 68 Median bolus clearance time: 12 | Not change: 70.4% Improvement: 17.8% De novo: 17.8% |
| Thereaux et al. [ | 6 | - | - | - | pH-metry | Group 1 Median DMS: 23.8 TAET: 5.6 % Group 2 Median DMS: 20.6 TAET: 5.9 % | Improvement: 33% De novo: 69% |
| Yormaz et al. [ | 6-12-24 | - | - | - | Impedance | Group A (24-month follow-up) Median DMS: 5.83 (1.74–23.6) TAET: 2.31 % (0.76–6.52) Median NRE > 5: 3.32 (1.4–7.3) Group B (24-month follow-up) Median DMS: 7.29 (2.37–25.1) TAET: 3.57 % (1.52–11.82) Median NRE > 5: 4.27 (2.3–7.5) | Improvement of AET and DMS |
Variables are expressed as mean ± standard deviation. HRM high-resolution manometry, LES low esophageal sphincter, LESP low esophageal sphincter pressure, NSEMD non-specific esophageal motility disorder, IEM: ineffective esophageal motility, DEA distal esophageal amplitude, DMS DeMeester score, NRE, number of reflux episodes, NRE > 5 number of reflux episodes longer than 5 min, LER longest episode of reflux (minutes), TAET total acid exposure time, TAE total acid exposure, LESR residual pressure of low esophageal sphincter, IGP intragastric pressure, DCI distal contractile integral (mmHg · cm · s), IEM ineffective esophageal motility, IRP integrated relaxation pressure, IRP4 integrated relaxation pressure over 4 s, AET acid exposure time
Fig. 2Lower esophageal sphincter resting pressure trend
Fig. 3DeMeester score trend
SymptomLate esophagogastric anatomic and s evaluation
| Author | Symptom assessment tool | Preoperative results | Postoperative results |
|---|---|---|---|
| Braghetto et al. [ | - | - | - |
| Gorodner et al. [ | Standard questionnaire | Heartburn: 0.4 ± 0.9 Regurgitation: 0.5 ± 1 Chest pain: 0.1 ± 0.3 Dysphagia: - Cough: 0.2 ± 0.8 | Heartburn: 0.5 ± 1.2 Regurgitation: 0.4 ± 0.6 Chest pain: 0.2 ± 0.8 Dysphagia: - Cough: 0 |
| Valezi et al. [ | - | - | - |
| De Angulo et al. [ | Presence of heartburn and regurgitation | Heartburn: 12 patients Regurgitation: 9 patients | Heartburn: 10 patients Regurgitation: 10 patients |
| Sioka et al. [ | Reflux symptoms assessment questionnaire | - | Heartburn: - Improvement: 7 patients - No change: 9 patients - Worsening: 2 patients Regurgitation: - Improvement: 2 patients - No change: 11 patients - Worsening: 5 patients |
| Rebecchi et al. [ | Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS) | Group A: 53.1 ± 10.5 Group B: 45.8 ± 9.6 | Group A: 13.1 ± 3.5 Group B: 31.7 ± 15.9 |
| Kleidi et al. [ | Likert scale | Total score: 4.9 ± 1.6 | Total score: 5.8 ± 1.3 |
| Gemici et al. [ | - | - | - |
| Coupaye et al. [ | Presence of heartburn and regurgitation | 6 patients | 18 patients |
| Del Genio et al. [ | Standard questionnaire | - | No modification of symptoms incidence |
| Tolone et al. [ | GERDQ questionnaire | n.r. | n.r. |
| Burgerhart et al | Reflux Disease Questionnaire (RDQ) | GERD score: 7.7 ± 8.3 | GERD score: 7.6 ± 6.3 |
| Georgia et al. [ | - | - | - |
| Świdnicka-Siergiejko et al. [ | GERDQ questionnaire | Median 6.5, IQR 6-7 | Median 6.7, IQR 6-8 |
| Thereaux et al | Presence of heartburn, regurgitation, or dysphagia | 17 patients | 29 patients |
| Yormaz et al. [ | Reflux Symptom Index (RSI) | n.r. | Group A - 24 months: 25 ± 2.2 Group B - 24 months: 26.4 ± 2.1 |
Variables are expressed as mean ± standard deviation. IQR interquartile range, GERD gastroesophageal reflux disease, n.r. not reported